company-logo

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.

Botanix Pharmaceuticals Dividend Announcement

Botanix Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Botanix Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Botanix Pharmaceuticals Dividend History

Botanix Pharmaceuticals Dividend Yield

Botanix Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Botanix Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Botanix Pharmaceuticals Financial Ratios

P/E ratio-42.98
PEG ratio0.50
P/B ratio6.56
ROE-21.55%
Payout ratio0.00%
Current ratio22.21
Quick ratio21.89
Cash Ratio21.25

Botanix Pharmaceuticals Dividend FAQ

Does Botanix Pharmaceuticals stock pay dividends?
Botanix Pharmaceuticals does not currently pay dividends to its shareholders.
Has Botanix Pharmaceuticals ever paid a dividend?
No, Botanix Pharmaceuticals has no a history of paying dividends to its shareholders. Botanix Pharmaceuticals is not known for its dividend payments.
Why doesn't Botanix Pharmaceuticals pay dividends?
There are several potential reasons why Botanix Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Botanix Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Botanix Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Botanix Pharmaceuticals a dividend aristocrat?
Botanix Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Botanix Pharmaceuticals a dividend king?
Botanix Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Botanix Pharmaceuticals a dividend stock?
No, Botanix Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Botanix Pharmaceuticals stocks?
To buy Botanix Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Botanix Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.